Dr. Loonbeek Anesthesie: what changed
What changed
Dr. Loonbeek Anesthesie
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€149,140
2024 · €150,182-€1,042
Equity
€720,283
2024 · €642,233+€78,051
Cash
€185,376
2024 · €106,745+€78,630
Balance sheet total
€727,764
2024 · €648,029+€79,736
Largest movements
Assets
- Cash +€78,630
up €78,630 (+73.7%), from €106,745 to €185,376
mainly Net result for the year (+€149,140) and Depreciation (+€7,411)
Equity and liabilities
- Reserves +€78,051
up €78,051 (+12.4%), from €629,833 to €707,883
Income statement
- Depreciation +€3,367
up €3,367 (+83.3%), from €4,044 to €7,411
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€150,182
Gross operating margin
+€1,277
Depreciation
-€3,367
Other operating charges
+€41
Financial income
-€61
Financial charges
+€533
Taxes
+€536
Result 2025
€149,140
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€150,918
Investment
-€1,199
Financing
-€71,089
Cash 2024
€106,745
From operations (derived)
+€150,918
Net result for the year
+€149,140
Depreciation
+€7,411
Receivables within one year
-€7,067
Deferred charges and accrued income
-€250
Tax, wage and social debts
+€1,685
Investment (derived)
-€1,199
Investment in fixed assets (net)
-€1,199
Current investments
+€0
Financing
-€71,089
Contributions, distributions and other
-€71,089
Cash 2025
€185,376
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €648,029 | €727,764 | +€79,736 | +12.3% |
| Fixed assets | 21/28 | €38,902 | €32,690 | -€6,212 | -16.0% |
| Tangible fixed assets | 22/27 | €38,902 | €32,690 | -€6,212 | -16.0% |
| Plant, machinery and equipment | 23 | €4,785 | €3,646 | -€1,139 | -23.8% |
| Furniture and vehicles | 24 | €30,482 | €25,796 | -€4,686 | -15.4% |
| Other tangible fixed assets | 26 | €3,635 | €3,247 | -€387 | -10.7% |
| Current assets | 29/58 | €609,127 | €695,075 | +€85,948 | +14.1% |
| Amounts receivable after more than one year | 29 | €90,000 | €90,000 | = | 0.0% |
| Other amounts receivable | 291 | €90,000 | €90,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €231,554 | €238,621 | +€7,067 | +3.1% |
| Trade receivables | 40 | €2,998 | €3,146 | +€148 | +4.9% |
| Other amounts receivable | 41 | €228,556 | €235,476 | +€6,920 | +3.0% |
| Current investments | 50/53 | €179,346 | €179,346 | -€0 | 0.0% |
| Cash at bank and in hand | 54/58 | €106,745 | €185,376 | +€78,630 | +73.7% |
| Deferred charges and accrued income | 490/1 | €1,482 | €1,732 | +€250 | +16.9% |
| Total equity and liabilities | 10/49 | €648,029 | €727,764 | +€79,736 | +12.3% |
| Equity | 10/15 | €642,233 | €720,283 | +€78,051 | +12.2% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €629,833 | €707,883 | +€78,051 | +12.4% |
| Distributable reserves | 133 | €629,833 | €707,883 | +€78,051 | +12.4% |
| Amounts payable | 17/49 | €5,796 | €7,481 | +€1,685 | +29.1% |
| Amounts payable within one year | 42/48 | €5,796 | €7,481 | +€1,685 | +29.1% |
| Taxes, remuneration and social security | 45 | €5,796 | €7,481 | +€1,685 | +29.1% |
| Taxes | 450/3 | €5,796 | €7,481 | +€1,685 | +29.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,044 | €7,411 | +€3,367 | +83.3% |
| Other operating charges | 640/8 | €502 | €462 | -€41 | -8.1% |
| Gross operating margin | 9900 | €218,520 | €219,797 | +€1,277 | +0.6% |
| Operating profit (loss) | 9901 | €213,974 | €211,924 | -€2,050 | -1.0% |
| Financial income | 75/76B | €2,611 | €2,549 | -€61 | -2.3% |
| Recurring financial income | 75 | €2,611 | €2,549 | -€61 | -2.3% |
| Financial charges | 65/66B | €1,998 | €1,465 | -€533 | -26.7% |
| Recurring financial charges | 65 | €1,998 | €1,465 | -€533 | -26.7% |
| Profit (loss) for the period before taxes | 9903 | €214,587 | €213,008 | -€1,578 | -0.7% |
| Income taxes | 67/77 | €64,405 | €63,869 | -€536 | -0.8% |
| Profit (loss) for the period | 9904 | €150,182 | €149,140 | -€1,042 | -0.7% |
| Profit (loss) for the period to be appropriated | 9905 | €150,182 | €149,140 | -€1,042 | -0.7% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.